Abstract:Suppressed interferon regulatory factor 8 (IRF8) contributes to cell proliferation and leukemogenesis of T‐cell acute lymphoblastic leukemia (T‐ALL) via transcriptional regulation of PIK3R5 and activation of phosphatidylinositol 3‐kinase (PI3K)/AKT pathway. High expression of fat mass‐ and obesity‐associated protein (FTO) in T‐ALL inhibits IRF8 expression by binding to m6A sites in 3' untranslated region (UTR) of IRF8 messenger RNA (mRNA) and erasing m6A methylation modification, thereby promoting IRF8 mRNA degradation. T‐cell acute lymphoblastic leukemia (T‐ALL) is an aggressive hematological malignancy with a poor prognosis, urging for novel therapeutic targets and treatment strategies. N6‐methyladenosine (m6A) is a crucial methylation modification that affects the pathogenesis of leukemia by regulating the mRNA of key genes. Interferon regulatory factor 8 (IRF8) is a crucial transcription factor for hematological lineage commitment, but its role in T‐ALL is unclear. Here, IRF8 is shown to suppress T‐ALL. The expression of IRF8 is abnormally silenced in patients with T‐ALL. Knockout of Irf8 significantly hastens the progression of Notch1‐induced T‐ALL in vivo. Overexpression of IRF8 suppresses the proliferation and invasion of T‐ALL cells by inhibiting the phosphatidylinositol 3‐kinase/AKT signaling pathway. The fat mass‐ and obesity‐associated protein (FTO), an m6A demethylase, is responsible for directly binding to m6A sites in 3′ untranslated region of IRF8 messenger RNA (mRNA) and inducing mRNA degradation via m6A modification. Targeting the FTO‐IRF8 axis is used as a proof of concept therapy; inhibition of FTO's demethylase activity drastically alleviates the proliferation of leukemic cells and prolongs the survival of T‐ALL mice by restoring IRF8 expression. This study elucidates the pathogenesis of T‐ALL from the perspective of epitranscriptomics and provides new insight into the genetic mechanisms and targeted therapy of T‐ALL.

Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T‐cell acute lymphoblastic leukemia

Author Response for "downregulation of FAPP2 Gene Induces Cell Autophagy and Inhibits PI3K/AKT/mTOR Pathway in T‐cell Acute Lymphoblastic Leukemia"

SIRT1 Regulates the Phosphorylation and Degradation of P27 by Deacetylating CDK2 to Promote T-cell Acute Lymphoblastic Leukemia Progression.

FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression

Tet2 Downregulation Promotes Aml Cell Proliferation Via Pim-1 Expression

FAPP2 Promotes Tumor Cell Growth in Human Colon Cancer Through Activation of Wnt Signaling

LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia

Alantolactone Inhibits Cell Autophagy and Promotes Apoptosis Via AP2M1 in Acute Lymphoblastic Leukemia

Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia

Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia

Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia

Subcellular Proteome Analysis Reveals Apoptotic Vulnerability of T-Cell Acute Lymphoblastic Leukemia.

Inhibition of BCL11B Induces Downregulation of PTK7 and Results in Growth Retardation and Apoptosis in T-cell Acute Lymphoblastic Leukemia

TAF‑Iβ Deficiency Inhibits Proliferation and Promotes Apoptosis by Rescuing PP2A and Inhibiting the AKT/GSK‑3β Pathway in Leukemic Cells

ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming

Inhibition of the M6a Reader IGF2BP2 As a Strategy Against T-cell Acute Lymphoblastic Leukemia

Notch and Phosphatidylinositide 3-Kinase/phosphatase and Tensin Homolog Deleted on Chromosome Ten/Akt/Mammalian Target of Rapamycin (mtor) Signaling in T-Cell Development and T-Cell Acute Lymphoblastic Leukemia

FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway

USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis

Activation of CaMKIIγ Potentiates T-cell Acute Lymphoblastic Leukemia Leukemogenesis Via Phosphorylating FOXO3a

PD-1 Signalling Defines and Protects Leukaemic Stem Cells from T Cell Receptor-Induced Cell Death in T Cell Acute Lymphoblastic Leukaemia